Alloferons—immunomodulatory peptides
The invention belongs to the field of biologically active peptides specifically stimulating antiviral, antimicrobial and antitumor activity of the human and animal immune system.
1. A method of manufacturing a composition having immunomodulatory activity, comprising combining a peptide of up to 30 amino acid residues comprising the amino acid sequence of any one of SEQ ID NOS: 1-4, or a pharmaceutically active salt or ether of the peptide with a conventional additive.
2. The method of claim 1 , wherein said peptide comprises SEQ ID NO:4.
3. The method of claim 1 , wherein the peptide consists of less than 30 amino acids.
4. The method of claim 1 , wherein the composition is a pharmaceutical that exhibits at least one of interferon inducing activity, antiviral activity, antitumor activity or stimulation of the cytotoxic activity of human or animal lymphocytes.
5. The method of claim 1 , wherein the composition is a pharmaceutical useful for the treatment or prophylaxis of at least one of an immune deficient condition, an infection, a viral infection, a fungal systemic infection, and an oncological disease.
6. A method of treating a condition, comprising administering to a subject in need thereof an effective amount of the immunomodulatory composition made by the method of claim 1 .
7. The method of claim 6 wherein said condition is selected from the group consisting of an immune deficient condition, an infection and an oncology.